Arkema S.A. (ARKAF)
| Market Cap | 5.60B -1.6% |
| Revenue (ttm) | 10.23B -7.5% |
| Net Income | 19.60M -87.4% |
| EPS | 0.26 -94.1% |
| Shares Out | n/a |
| PE Ratio | 285.60 |
| Forward PE | 12.88 |
| Dividend | 4.06 (6.22%) |
| Ex-Dividend Date | May 23, 2025 |
| Volume | n/a |
| Average Volume | 383 |
| Open | 65.28 |
| Previous Close | 65.28 |
| Day's Range | 65.28 - 65.28 |
| 52-Week Range | 59.00 - 88.66 |
| Beta | 0.96 |
| RSI | 44.54 |
| Earnings Date | May 6, 2026 |
About Arkema
Arkema S.A., together with its subsidiaries, manufactures and sells specialty materials in Europe, the United States, Canada, Mexico, China, Hong Kong, Taiwan, and internationally. It operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The company provides solutions for construction, renovation of buildings, and DIY; high performance adhesives for durable goods, and adhesive solutions for packaging and non-woven; and supplies technologies used in building activities for businesses and ind... [Read more]
Financial Performance
In 2025, Arkema's revenue was 9.07 billion, a decrease of -4.99% compared to the previous year's 9.54 billion. Earnings were 39.00 million, a decrease of -88.46%.
Financial numbers in EUR Financial StatementsNews
Arkema downgraded to Reduce from Hold at Kepler Cheuvreux
Kepler Cheuvreux analyst Martin Roediger downgraded Arkema (ARKAY) to Reduce from Hold with a EUR 60 price target
Q1 2026 Arkema SA Earnings Call Transcript
Q1 2026 Arkema SA Earnings Call Transcript
Arkema Earnings Call Transcript: Q1 2026
Q1 2026 delivered stable volumes and strong Specialty Materials growth, offset by currency headwinds and weak U.S./Europe demand. EBITDA rose 14% sequentially but fell year-on-year; price increases and major projects are set to support Q2 and full-year guidance.
Arkema downgraded to Hold from Buy at Berenberg
Berenberg analyst Sebastian Bray downgraded Arkema (ARKAY) to Hold from Buy with an unchanged price target of EUR 62. The firm cites valuation for the downgrade with the shares reaching…
Arkema upgraded to Market Perform from Underperform at Bernstein
Bernstein upgraded Arkema (ARKAY) to Market Perform from Underperform with a price target of EUR 64, up from EUR 54. The firm says the company has reached the end of…
Arkema price target raised to EUR 50 from EUR 49 at Deutsche Bank
Deutsche Bank analyst Virginie Boucher-Ferte raised the firm’s price target on Arkema (ARKAY) to EUR 50 from EUR 49 and keeps a Hold rating on the shares. Published first on…
Arkema price target raised to EUR 83 from EUR 78 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Arkema (ARKAY) to EUR 83 from EUR 78 and keeps an Overweight rating on the shares.
Arkema price target raised to EUR 62 from EUR 60 at Berenberg
Berenberg raised the firm’s price target on Arkema (ARKAY) to EUR 62 from EUR 60 and keeps a Buy rating on the shares.
Arkema downgraded to Hold from Buy at Kepler Cheuvreux
Kepler Cheuvreux downgraded Arkema (ARKAY) to Hold from Buy with a EUR 65 price target
Arkema Earnings Call Transcript: Q4 2025
2025 saw revenue and EBITDA decline amid weak demand in Europe and the U.S., but strong cash generation and cost savings exceeded targets. Outlook for 2026 is cautious, with slight EBITDA growth expected and continued focus on cost control and project ramp-up.
Arkema upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs upgraded Arkema (ARKAY) to Buy from Neutral with a price target of EUR 71, up from EUR 51. The firm adjusted seven ratings in the European chemicals group,…
Arkema price target lowered to EUR 50 from EUR 55 at JPMorgan
JPMorgan lowered the firm’s price target on Arkema (ARKAY) to EUR 50 from EUR 55 and keeps a Neutral rating on the shares.
Arkema price target lowered to EUR 70 from EUR 80 at Citi
Citi lowered the firm’s price target on Arkema (ARKAY) to EUR 70 from EUR 80 and keeps a Buy rating on the shares.
Arkema downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Virginie Boucher-Ferte downgraded Arkema (ARKAY) to Hold from Buy with a price target of EUR 49, down from EUR 65. The firm reduced estimates to reflect macro…
Arkema price target raised to EUR 60 from EUR 58 at Berenberg
Berenberg raised the firm’s price target on Arkema (ARKAY) to EUR 60 from EUR 58 and keeps a Buy rating on the shares.
Arkema downgraded to Underweight from Equal Weight at Barclays
Barclays downgraded Arkema (ARKAY) to Underweight from Equal Weight with a EUR 47 price target The firm has a negative view on the European chemicals and ingredients group. Barclays prefers…
Arkema Earnings Call Transcript: Q3 2025
Q3 2025 saw sales down 8.6% year-on-year amid weak U.S. and European demand, but strong growth in Asia and targeted markets like batteries and fluorospecialties. Cost savings and disciplined capital allocation supported cash flow, with 2025 EBITDA guidance set at €1.25–1.3 billion.
Arkema price target lowered to EUR 58 from EUR 75 at Berenberg
Berenberg analyst Sebastian Bray lowered the firm’s price target on Arkema (ARKAY) to EUR 58 from EUR 75 and keeps a Buy rating on the shares.
Arkema price target lowered to EUR 55 from EUR 65 at JPMorgan
JPMorgan lowered the firm’s price target on Arkema (ARKAY) to EUR 55 from EUR 65 and keeps a Neutral rating on the shares.
Arkema price target lowered to EUR 80 from EUR 83 at Citi
Citi analyst Ranulf Orr lowered the firm’s price target on Arkema (ARKAY) to EUR 80 from EUR 83 and keeps a Buy rating on the shares.
Arkema price target lowered to EUR 65 from EUR 70 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Arkema (ARKAY) to EUR 65 from EUR 70 and keeps a Buy rating on the shares.
Arkema price target lowered to EUR 70 from EUR 76 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Arkema (ARKAY) to EUR 70 from EUR 76 and keeps a Buy rating on the shares.
Arkema price target lowered to EUR 76 from EUR 80 at Deutsche Bank
Deutsche Bank analyst Virginie Boucher-Ferte lowered the firm’s price target on Arkema (ARKAY) to EUR 76 from EUR 80 and keeps a Buy rating on the shares. Published first on…
ARKEMA Strengthens Its Fluorospecialties Business with Its New Forane® 1233zd Production Unit in the US
PARIS LA DÉFENSE--(BUSINESS WIRE)--Regulatory News: With the successful start-up of its 15 kt Forane® 1233zd production unit in Calvert City, Kentucky, Arkema (Paris:AKE) continues to develop its low ...